Tue.Jun 13, 2023

article thumbnail

Prescribing Alert Increases Rates of Naloxone, Opioid Co-Prescriptions

Drug Topics

The alert was implemented after passage of a state senate bill.

468
468
article thumbnail

The ingredients of a successful biopharma collaboration

PharmaVoice

Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.

264
264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Contraceptives, Gender-Affirming Care, and Other Hot Topics for Pharmacists

Drug Topics

What is the state of OTC contraception, what’s next for IUDs, and why are so many transgender people denied care?

460
460
article thumbnail

AMA asks doctors to de-emphasize use of BMI in gauging health and obesity

STAT

CHICAGO — The American Medical Association on Tuesday strongly criticized the body mass index , urging doctors to de-emphasize its use in assessing health and obesity and acknowledging that the measurement has been used for “racist exclusion” and has caused “historical harm.” The AMA, one of the largest medical groups in the U.S., voted to adopt this policy during its annual meeting here.

141
141
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How the Workplace Can Impact Respiratory Health

Drug Topics

A recent study examined the effects that different work environments can have on adults with asthma.

247
247
article thumbnail

Teens seeking addiction care unlikely to be offered standard medication

STAT

Adolescents who seek treatment for opioid addiction at an inpatient facility are more likely to be offered horseback riding than given full access to a common, highly effective addiction medication. According to a new research paper, just one out of every eight residential treatment facilities open to patients ages 16 or 17 offers full access to buprenorphine.

141
141

More Trending

article thumbnail

Suicide hotlines promise anonymity. Dozens of their websites send sensitive data to Facebook

STAT

This article was co-published with The Markup , a nonprofit newsroom that investigates how powerful institutions are using technology to change our society. Sign up for its newsletters here. Websites for mental health crisis resources across the country — which promise anonymity for visitors, many of whom are at a desperate moment in their lives — have been quietly sending sensitive visitor data to Facebook, The Markup has found.

129
129
article thumbnail

Psychedelic Therapy Can Advance the Scope of Oncology Care

Pharmacy Times

Providing this treatment for patients with cancer may be a smoother transition for oncology professionals than they might expect.

123
123
article thumbnail

Medicare Advantage overpayments could top $75B this year: study

Fierce Healthcare

Legislators and policymakers have put payments to Medicare Advantage (MA) plans under the microscope, and new analysis highlights why. | Legislators and policymakers have put payments to Medicare Advantage plans under the microscope, and new analysis highlights why.

122
122
article thumbnail

SGLT2 Inhibitors Play Significant, Growing Role in Glycemic Control

Pharmacy Times

Stormi Gale, PharmD, BCCP, a cardiology pharmacy specialist at Novant Health, discussed the important role of SGLT2 inhibitors in glycemic control.

122
122
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Biotech executive nominated to Biogen board is mother of director’s child, records show

STAT

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close. What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtaine

117
117
article thumbnail

Novel Treatment Shows Promise for Hypertension-Induced Cognitive Impairment

Pharmacy Times

Study evaluates the interaction between excessive salt intake and hypertension, cognitive dysfunction, and dementia.

120
120
article thumbnail

Demand for GLP-1 drugs is growing. Here's why payers are hesitant to cover them for weight loss

Fierce Healthcare

Insurers find themselves in the position of needing to say "yes" or "no" to GLP-1 drugs as more people seek them for weight loss. | Ozempic, estimated to cost about $10,000 a year per person, and other GLP-1 drugs could put significant financial strain on payers as demand grows.

Insurance 116
article thumbnail

Opinion: How predominantly white hospital leadership teams hurt care for people of color

STAT

Last year, my father, a Jamaican immigrant with Medicaid insurance, passed away from a heart attack. He was only 63 years old. As he received care, he expressed discomfort with the predominantly white teams handling his case. He believed that both clinicians and non-clinical staff discriminated against him because of his racial and ethnic identity, as well as his public insurance status.

Hospitals 109
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Appeals court grants partial stay in ACA preventive care case

Fierce Healthcare

The Affordable Care Act's (ACA's) preventive care mandate remains in effect as a federal appeals court mulls a legal challenge to the requirements. | The Affordable Care Act's preventive care mandate remains in effect as a federal appeals court mulls a legal challenge to the requirements.

110
110
article thumbnail

Teva to pay Kentucky $1.407M to settle state's price fixing claims

Drug Store News

Teva will pay the state $1.407 million, and the state will dismiss all of its claims against Teva and its affiliates once payment has been made.

106
106
article thumbnail

Rural Illinois hospital says 2021 ransomware attack partially to blame for closure

Fierce Healthcare

A rural Illinois hospital closure slated for the end of the week has been attributed in part to a multiweek ransomware incident the organization suffered in early 2021, marking what experts say is | St. Margaret's Health leadership listed a costly multiweek system lockout as a primary factor for its decision to close its doors this week, representing a new milestone for cyberattacks against healthcare organizations.

Hospitals 106
article thumbnail

STAT+: Bitter infighting leads 15 chapters to break away from leading ALS advocacy group

STAT

After a bitter dispute, the ALS Association has settled a lawsuit filed by 15 chapters that chafed at managerial moves by the national organization and will now break away to form an alternative organization for patients and their families combating the debilitating disease. The details of the settlement have not yet been disclosed, but in a statement, the ALS Association confirmed that a deal was reached that “allows for separation of the… chapters that desire to operate independe

106
106
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

World’s largest lutetium-177 production site opens

European Pharmaceutical Review

A new therapeutic radionuclide facility, the world’s largest production site of lutetium-177, has opened in Germany. ITM Isotope Technologies Munich SE ( ITM )’s manufacturing plant in Neufahrn near Munich will produce the innovative medical isotope for targeted cancer therapies. “Radiopharmaceuticals are an essential new class of anti-cancer drugs that have the potential to improve therapy outcomes and quality of life for many patients.

105
105
article thumbnail

Biogen refreshes board as chairman departs, adding a Langer while leaving 2 empty seats

Fierce Pharma

Biogen has taken a step to “significantly refresh” its board of directors, departing chair Stelios Papadopoulos, Ph.D., said. | Biogen has taken a step to “significantly refresh” its board of directors, departing chair Stelios Papadopoulos, Ph.D., said. But the reported romantic relationship between a new nominee and a departing member raises questions about one appointment.

100
100
article thumbnail

Chikungunya vaccine demonstrates 99 percent immune response

European Pharmaceutical Review

If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. The chikungunya vaccine candidate is the only one globally for which regulatory review processes are underway.

article thumbnail

Bubble protects skin with mineral SPF 40 sunscreen launch

Drug Store News

Bubble’s new mineral SPF 40 products include Plus One, a tinted sunscreen, and Solar Mate, an invisible sunscreen.

100
100
article thumbnail

STAT+: Key House Republican escalates rhetoric against PBMs

STAT

WASHINGTON — A key House Republican ramped up his criticism of pharmacy benefit managers Tuesday, calling for the government to dismantle companies that have consolidated drug supply chain operations. “We should break these PBMs up,” House Oversight Committee Chair James Comer (R-Ky.) said during an Education and Workforce Committee hearing.

article thumbnail

Majority of senior health system execs say nursing shortage is critical, poll finds. What are they doing to address it?

Fierce Healthcare

Majority of senior health system execs say nursing shortage is critical, poll finds. What are they doing to address it?

98
article thumbnail

STAT+: Biogen’s boardroom scandal saddles CEO with first crisis

STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board. Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company.

98
article thumbnail

Beacon Therapeutics enters gene therapy arena with $120m launch

Pharmaceutical Technology

Beacon Therapeutics has kickstarted its entry into the gene therapy field with a $120m Series A financing. The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with two proprietary preclinical programmes.

98
article thumbnail

STAT+: Transplant patients say new Medicare guidance puts their donated organs at risk

STAT

Margaret Gamble was supposed to receive a blood test in the mail in May. It’s a regularly scheduled test to check if her kidney — the second she’s received in a transplant — has been damaged in any way. Her kidney needs to be constantly monitored since it’s vulnerable to infections or, critically, rejection by her immune system.

article thumbnail

Class II approval revs up Huma’s SaMD platform

pharmaphorum

Class II approval revs up Huma’s SaMD platform Phil.

98
article thumbnail

Hospitals are testing AI to communicate with patients. They still don’t know how to talk to them about it

STAT

Health systems across the country are exploring blending artificial intelligence into their communication with patients, from billing to after-hours messages about medication or symptoms. But how best to actually talk to patients about the technology and its risks is still an open question. STAT asked six health system leaders how they are disclosing their use of AI to the patients the technology is supposed to benefit.

article thumbnail

'Podnosis': Price negotiations and longevity research

Fierce Healthcare

Dogs are our best friends. So how can we help them live longer? Biotech founder Celine Halioua is working on drugs to expand dogs' longevity. | 'Podnosis': Are canines the secret to anti-aging meds and the benefits and challenges of direct contracting and purchase alliances.

98
article thumbnail

STAT+: Pharmalittle: Exec nominated to Biogen board is mother of outgoing director’s child; telehealth company pauses Wegovy ads amid shortages

STAT

Top of the morning to you, and a fine one it is. Sunny skies and cool breezes are enveloping the Pharmalot campus, where the official mascots are snoozing in their respective corners and the short person is sleeping in. As for us, we are going about the usual routine at this time of day — brewing cups of stimulation. Our choice is, once again, roasted coconut.

98
article thumbnail

Ingredient-infused success

Drug Store News

Whether driven by TikTok or dermatologists’ recommendations, consumers are on the hunt for buzzy ingredients in bath and skin care products.

98
article thumbnail

STAT+: Moving past regulatory obstacles, Protagonist Therapeutics looks to pivotal trial for its rare blood disorder therapy

STAT

FRANKFURT, Germany — Protagonist Therapeutics has run into some speed bumps as it’s developed its medicine for a rare blood cancer characterized by the overproduction of red blood cells. In 2021, the Food and Drug Administration put studies of the drug, rusfertide, on hold after a mouse study raised concerns about skin malignancies (the hold was lifted quickly , after less than a month).

FDA 98